Suzhou Wanxiang Technology Co., Ltd. (301180.SZ)
CNY 17.63
(2.32%)
CNY 17.63
(2.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 153.39 Million | 335.02 Million | 97.21 Million | 36.51 Million | 117.66 Million | 121.38 Million |
| Net Income | 25.08 Million | 185.56 Million | 175.87 Million | 117.41 Million | 73.52 Million | 37.8 Million |
| Depreciation & Amortization | 55.92 Million | 43.16 Million | 39.53 Million | 1.1 Million | 291.67 Thousand | 276.67 Thousand |
| Deferred income taxes | -2.34 Million | 2.21 Million | -3.78 Million | -4.11 Million | 802.1 Thousand | -1.58 Million |
| Stock-based compensation | 7.81 Million | 4.16 Million | 2.75 Million | 1.56 Million | -802.1 Thousand | 83.75 Million |
| Change in working capital | 52.97 Million | 93.49 Million | -145.04 Million | -157.08 Million | 1.69 Million | -78.5 Million |
| Other non-cash items | 88.22 Million | 12.8 Million | 26.84 Million | 75.08 Million | 42.15 Million | 161.8 Million |
| Investing Cash Flow | -145.68 Million | -278.6 Million | -155.88 Million | -148.23 Million | -138.43 Million | -107.89 Million |
| Investments in PPE | -222.03 Million | -146.38 Million | -158.86 Million | -138.64 Million | -179.97 Million | -110.66 Million |
| Acquisitions | -21.19 Million | 1.74 Million | 885.4 Thousand | 671.14 Thousand | 182.73 Thousand | 2941.59 |
| Investment purchases | -795 Million | -948 Million | -3.22 Million | -64.19 Million | -40.71 Million | - |
| Sales/Maturities of investments | 892.53 Million | 810.84 Million | 3.24 Million | 64.24 Million | 40.76 Million | - |
| Other Investing Activities | 97.92 Million | 3.18 Million | 2.07 Million | -10.31 Million | 41.3 Million | 2.76 Million |
| Financing Cash Flow | -37.05 Million | -287.42 Million | 481.72 Million | 102.98 Million | 29.04 Million | 17.82 Million |
| Debt repayment | -12 Million | -361.22 Million | -379.01 Million | -284.68 Million | -112.52 Million | -33.04 Million |
| Dividends payments | -20 Million | -20 Million | -6.31 Million | -5.45 Million | -142.39 Million | -35.59 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 957.74 Thousand | 95.67 Million | 867.05 Million | 393.12 Million | 283.95 Million | 86.46 Million |
| Accounts receivables | 28.91 Million | 131.09 Million | -8.2 Million | -193.07 Million | -5.24 Million | -94.45 Million |
| Accounts payables | -44.76 Million | -42.09 Million | 5.1 Million | 87.1 Million | 16.72 Million | 54.02 Million |
| Inventory | 61.23 Million | 2.27 Million | -138.16 Million | -46.99 Million | -10.58 Million | -36.48 Million |
| Other working capital | 7.59 Million | 2.21 Million | -3.78 Million | -4.11 Million | 802.08 Thousand | -42.02 Million |
| Cash at beginning of period | 249.95 Million | 477.5 Million | 55.16 Million | 65.89 Million | 57.09 Million | 27.87 Million |
| Cash at end of period | 223.85 Million | 246.45 Million | 477.5 Million | 55.16 Million | 65.89 Million | 57.09 Million |
| Capital Expenditure | -222.03 Million | -146.38 Million | -158.86 Million | -138.64 Million | -179.97 Million | -110.66 Million |
| Effect of forex changes on cash | 3.98 Million | -53.75 Thousand | -711.8 Thousand | -2 Million | 517.95 Thousand | -2.08 Million |
| Net cash flow / Change in cash | -26.09 Million | -231.05 Million | 422.33 Million | -10.72 Million | 8.79 Million | 29.22 Million |
| Free Cash Flow | -68.63 Million | 188.64 Million | -61.64 Million | -102.12 Million | -62.3 Million | 10.72 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.47 Million | 13.85 Million | 174.19 Thousand | -7.54 Million | 25.08 Million | 9.38 Million |
| Depreciation & Amortization | - | 15.27 Million | 15.27 Million | 14.89 Million | 55.92 Million | 14.89 Million |
| Deferred income taxes | - | - | - | - | -2.34 Million | - |
| Stock-based compensation | - | 3.41 Million | - | 7.81 Million | 7.81 Million | -3.89 Million |
| Change in working capital | - | -50.08 Million | - | 97.74 Million | 52.97 Million | -65.36 Million |
| Other non-cash items | -55.19 Million | 16.03 Million | 44.56 Million | 85.34 Million | 88.22 Million | -8.52 Million |
| Investing Cash Flow | -21.23 Million | -59.13 Million | -103.75 Million | -8.38 Million | -145.68 Million | -35.06 Million |
| Investments in PPE | -64.26 Million | -72.86 Million | -54.9 Million | -59.14 Million | -222.03 Million | -23.55 Million |
| Acquisitions | 2.01 Million | 300 Thousand | 475.22 Thousand | -21.3 Million | -21.19 Million | -402.32 Thousand |
| Investment purchases | - | -40 Million | -50 Million | -98.3 Million | -795 Million | -241.69 Million |
| Sales/Maturities of investments | 41.02 Million | 51.03 Million | 674.31 Thousand | 170.37 Million | 892.53 Million | 230.58 Million |
| Other Investing Activities | 2.01 Million | 2.39 Million | -48.85 Million | 72.35 Million | 97.92 Million | 0.13 |
| Financing Cash Flow | 13.09 Million | -13.68 Million | -1.02 Million | -266.34 Thousand | -37.05 Million | -34.49 Million |
| Debt repayment | -32.5 Million | - | - | - | -12 Million | -12 Million |
| Dividends payments | -10 Million | -10 Million | - | -20 Million | -20 Million | -20.05 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 31.32 Million | -1.03 Million | -1.02 Million | 25.74 Million | 957.74 Thousand | -2.43 Million |
| Accounts receivables | - | -61.04 Million | - | 28.91 Million | 28.91 Million | -26.14 Million |
| Accounts payables | - | - | - | - | -44.76 Million | - |
| Inventory | - | 7.55 Million | - | 61.23 Million | 61.23 Million | -39.28 Million |
| Other working capital | - | 3.41 Million | - | 7.59 Million | 7.59 Million | 59.46 Thousand |
| Cash at beginning of period | 106.27 Million | 164.81 Million | 223.85 Million | 166.97 Million | 249.95 Million | 235.84 Million |
| Cash at end of period | 49.53 Million | 109.03 Million | 164.81 Million | 223.85 Million | 223.85 Million | 166.97 Million |
| Capital Expenditure | -64.26 Million | -72.86 Million | -54.9 Million | -59.14 Million | -222.03 Million | -23.55 Million |
| Effect of forex changes on cash | -883.94 Thousand | 2.41 Million | 1 Million | -126.55 Thousand | 3.98 Million | -170.31 Thousand |
| Net cash flow / Change in cash | -56.73 Million | -55.78 Million | -59.04 Million | 56.88 Million | -26.09 Million | -68.87 Million |
| Free Cash Flow | -111.98 Million | -58.24 Million | -10.16 Million | 3.75 Million | -68.63 Million | -22.7 Million |
SRGXF
001322
FCMGF
JBCHEPHARM
BASC
SAURASHCEM